摘要
本研究旨在评估阿尔茨海默病(AD)的神经精神性症状和区域灰质(GM)在使用基于体素的形态学测量(VBM)方法下的关系。从阿尔茨海默病神经影像学准则下选择85例AD患者的数据,208名轻度认知障碍(MCI)和131例健康对照组。个人VBM模型的整个样本中神经精神量表问卷的每个项目为变量,四个协变量为规定值,包括年龄、性别、颅内总体积(TIV)、简易精神状态检查(MMSE)评分。激越症状与左额叶、岛叶和双侧扣带皮质GM萎缩相关。运动行为异常(AMB)与右侧基底节区GM萎缩有关。VBM模型进行指定三个协变量(年龄,性别,TIV),不包括由MMSE标记AD严重程度相关的体素。该过程确认了第一个结果,并显示抑郁症和左额中回灰质萎缩之间的关联,激越症状和左侧额叶皮质GM萎缩相关,AMB与右下额叶皮质GM萎缩相关。分层多元回归分析使用这些额外的区域中提取的平均值证实了这些关联。最后,群组内(85例AD和41例MCI)VBM分析在一定程度上确认了结果。我们的研究结果表明,在AD相关的神经退行性疾病中GM萎缩的特异性模式诱发某些特定的神经精神症状,表明了不同的神经生物学机制。
关键词: 运动行为异常,激越,阿尔兹海默病,抑郁症,轻度认知障碍,神经精神症状,基于体素的形态学测量
Current Alzheimer Research
Title:Anatomical Correlates of the Neuropsychiatric Symptoms in Alzheimer’s Disease
Volume: 12 Issue: 3
Author(s): Xiaochen Hu, Dix Meiberth, Beate Newport, Frank Jessen and the Alzheimer’s Disease Neuroimaging Initiative
Affiliation:
关键词: 运动行为异常,激越,阿尔兹海默病,抑郁症,轻度认知障碍,神经精神症状,基于体素的形态学测量
摘要: The current study aimed to assess the relationship between the neuropsychiatric symptoms in Alzheimer’s disease (AD) and the regional grey matter (GM) volume using voxel based morphometry (VBM). Data of 85 AD patients, 208 subjects with mild cognitive impairment (MCI), and 131 healthy controls were selected from the Alzheimer’s Disease Neuroimaging Initiative. Individual VBM models across the entire sample for each items of the Neuropsychiatric Inventory Questionnaire as variables of interest were specified with four nuisance covariates, including age, sex, total intracranial volume (TIV), and Mini-Mental State Examination (MMSE) score. Agitation was related to the GM atrophy in the left inferior frontal/insula and bilateral retrosplenial cortices. Aberrant motor behavior (AMB) was related to the GM reductions in the right basal ganglia. The VBM models were recalculated by specifying three nuisance covariates (age, sex, TIV), and by excluding voxels related to AD severity by applying a MMSE mask. This procedure confirmed the first results, and additionally revealed associations between depression and GM atrophy in the left middle frontal cortex, between agitation and the GM atrophy in the left middle frontal cortex, and between AMB and GM reduction in the right inferior frontal cortex. Hierarchical multiple regression analyses using extracted mean GM value in these additional regions confirmed these associations. Finally, VBM analyses within a subgroup (85 AD patients and 41 MCI converters) largely confirmed the results. Our results suggest that specific patterns of GM atrophy within AD related neurodegeneration predispose to certain neuropsychiatric symptoms, suggesting distinct neurobiological mechanisms.
Export Options
About this article
Cite this article as:
Xiaochen Hu, Dix Meiberth, Beate Newport, Frank Jessen and the Alzheimer’s Disease Neuroimaging Initiative , Anatomical Correlates of the Neuropsychiatric Symptoms in Alzheimer’s Disease, Current Alzheimer Research 2015; 12 (3) . https://dx.doi.org/10.2174/1567205012666150302154914
DOI https://dx.doi.org/10.2174/1567205012666150302154914 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Protective Effect of Notoginsenoside R1 on an APP/PS1 Mouse Model of Alzheimer's Disease by Up-Regulating Insulin Degrading Enzyme and Inhibiting Aβ Accumulation
CNS & Neurological Disorders - Drug Targets Preface
Current Psychopharmacology Clinical Evidence of Herb-Drug Interactions: A Systematic Review by the Natural Standard Research Collaboration
Current Drug Metabolism GSK-3 Inhibitors: A New Class of Drugs for Alzheimer’s Disease Treatment
Current Drug Targets Editorial (Thematic Issue: The Link between Alzheimer’s Disease and Down Syndrome. A Historical Perspective)
Current Alzheimer Research New Pharmacological Approaches in Infants with Hypoxic-Ischemic Encephalopathy
Current Pharmaceutical Design Activation of Latent HIV-1 Expression by Protein Kinase C Agonists. A Novel Therapeutic Approach to Eradicate HIV-1 Reservoirs
Current Drug Targets Associations of Plasma BACE1 Level and BACE1 C786G Gene Polymorphism with Cognitive Functions in Patients with Type 2 Diabetes: A Cross- Sectional Study
Current Alzheimer Research Pathways of Acetylcholine Synthesis, Transport and Release as Targets for Treatment of Adult-Onset Cognitive Dysfunction
Current Medicinal Chemistry Experimental Fracture Protocols in Assessments of Potential Agents for Osteoporotic Fracture Healing Using Rodent Models
Current Drug Targets Ginkgo biloba Extract EGb761 Attenuates Hyperhomocysteinemia-induced AD Like Tau Hyperphosphorylation and Cognitive Impairment in Rats
Current Alzheimer Research Zederone Improves the Fecal Microbial Profile in Dementia Induced Rat Model: A First Report
CNS & Neurological Disorders - Drug Targets Endogenous Retroelements in Cellular Senescence and Related Pathogenic Processes: Promising Drug Targets in Age-Related Diseases
Current Drug Targets Editorial: Current Approaches in the Treatment of Neuropsychiatric Diseases
Current Topics in Medicinal Chemistry Advancement in Obesity Management: Leptin and Adiponectin Patents
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Executive Function and Diabetes Mellitus - A Stone Left Unturned?
Current Diabetes Reviews End-Stage Dementia Spark of Life: Reliability and Validity of the “GATOS” Questionnaire
Current Alzheimer Research Intestinal Barrier Dysfunction Participates in the Pathophysiology of Ischemic Stroke
CNS & Neurological Disorders - Drug Targets Brain Endothelial Cell-Cell Junctions: How to “Open” the Blood Brain Barrier
Current Neuropharmacology Therapeutic Agents in Alzheimer's Disease Through a Multi-targetdirected Ligands Strategy: Recent Progress Based on Tacrine Core
Current Topics in Medicinal Chemistry